Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): a randomized, open-label, multinational, phase 3b trial
Published July 17 in the Journal of the American Heart Association , researchers at Northwestern University analyzed data from the Medical Expenditure Panel Survey, reviewing nearly 1,900 participants who reported using a GLP-1 medication between 2017 and 2022
Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies
Having clear answers helps you communicate effectively with your provider
They can help you determine if it is an appropriate option for your specific situation and guide you toward a reputable source
But Ozempic may also improve libido in some men